Maintenance Therapy with Itraconazole after Treatment of Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome

Journal of the Medical Association of Thailand

Volumn 80, Issue 12, 1997, Pages 766-770

  Chotmongkol, Verajit ^a   Sukeepaisarncharoen, Wisut ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMPHOTERICIN B; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FEMALE; FOLLOW UP; FUNGAL MENINGITIS; HUMAN; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RECURRENT DISEASE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; FEMALE; HUMANS; ITRACONAZOLE; MALE; MENINGITIS, CRYPTOCOCCAL; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0031434575     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 1986; 104: 234-40.
2. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 104: 533-8.
3. Bozzette SA, Larsen RA, Chiu J, et al. A placebocontrolled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med 1991; 324: 580-4.
4. Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Cinical Trials Group and Mycoses Study Group. N Engl J Med 1992; 326: 793-8.
5. Saag MS. The NIAID Mycoses Study Group. Comparison of fluconazole versus itraconazole as maintenance therapy of AIDS-associated cryptococcal meningitis [abstract no 1218]. In : Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
6. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989; 149: 2301-8.
7. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37: 310-44.
8. Chotmongkol V, Sukeepaisarncharoen W, Thavornpitak Y. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. J Med Assoc Thai 1997; 80: 416-25.
9. Gallrado-Quesada S, Luelmo-Aguilar J, Guanyabens-Calvet C. Hepatotoxicity associated with itraconazole [letter]. Int J Dermatol 1995; 34: 589.
10. Lavrijsen AP, Balmus KJ, Nugteren-Huying WM, Roldaan AC, van't Wout JW, Stricker BH. Hepatic injury associated with Itraconazole. Lancet 1992; 340(8813): 251-2.